Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biochemistry. 2014 Jan 14;53(1):1-3. doi: 10.1021/bi400882s. Epub 2013 Dec 30.

MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors.

Author information

  • 1Institute for Molecular Bioscience, The University of Queensland , Brisbane, QLD 4072, Australia , and Discipline of Pharmacology, The University of Sydney , Sydney, NSW 2006, Australia.

Abstract

α-Conotoxins are competitive antagonists of nicotinic acetylcholine receptors (nAChRs). Their high selectivity and affinity for the various subtypes of nAChRs have led to significant advances in our understanding of the structure and function of these key ion channels. Here we report the discovery of a novel 4/7 α-conotoxin, MrIC from the venom duct of Conus marmoreus, which acts as an agonist at the endogenous human α7 nAChR in SH-SY5Y cells pretreated with PNU120596 (PNU). This unique agonist activity of MrIC at α7 nAChRs may guide the development of novel α7 nAChR modulators.

PMID:
24351107
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Write to the Help Desk